Literature DB >> 24049632

Sost, ECR5, Mef2C and van Buchem disease.

.   

Abstract

Entities:  

Year:  2012        PMID： 24049632      PMCID： PMC3727736          DOI： 10.1038/bonekey.2012.204

Source DB:  PubMed          Journal:  Bonekey Rep        ISSN： 2047-6396


× No keyword cloud information.
  1 in total

1.  Targeted deletion of Sost distal enhancer increases bone formation and bone mass.

Authors:  Nicole M Collette; Damian C Genetos; Aris N Economides; LiQin Xie; Mohammad Shahnazari; Wei Yao; Nancy E Lane; Richard M Harland; Gabriela G Loots
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-10       Impact factor: 11.205
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.